CorMedix (CRMD) Tops Q1 EPS by 16c

CorMedix (NASDAQ: CRMD) reported Q1 EPS of $0.32, $0.16 better than the analyst estimate of $0.16. Revenue for the quarter came in at $39.1 million versus the consensus estimate of $32.35 million.

For earnings history and earnings-related data on CorMedix (CRMD) click here.

You May Also Be Interested In

• Trump: Exxon, Chevron Are Making Too Much Money
• Bristol-Myers Squibb and AstraZeneca said to discuss megamerger - can it happen?
• Solaris Energy Infrastructure (SEI) call put ratio 3.1 calls to 1 put with a focus on August calls as share price up 7.7%